EUVIMED · CrossrefZeitschrift
The Medical Letter on Drugs and Therapeutics
ISSN 1523-2859 · The Medical Letter, Inc.
Neueste Artikel
Two New Drugs for Gonorrhea
Nerandomilast (Jascayd) for Idiopathic Pulmonary Fibrosis
Qlosi — Pilocarpine 0.4% Ophthalmic Solution for Presbyopia
Tisotumab Vedotin (Tivdak) for Cervical Cancer
Expanded Table: Some Oral Drugs for Chronic Insomnia (online only)
Teplizumab (Tzield) to Delay Onset of Type 1 Diabetes
COVID-19 Update: Tocilizumab (Actemra) FDA-Approved for Treatment of COVID-19 (online only)
Hemgenix - A Gene Therapy for Hemophilia B
Topical Roflumilast (Zoryve) for Plaque Psoriasis
Olopatadine/Mometasone (Ryaltris) for Allergic Rhinitis
In Brief: Furoscix - A Subcutaneous Furosemide Infusor for Heart Failure
In Brief: Finerenone (Kerendia) for Diabetic Kidney Disease
Adagrasib (Krazati) for NSCLC (online only)
Opdualag for Metastatic Melanoma
Lecanemab (Leqembi) for Alzheimer's Disease
Dupilumab (Dupixent) for Eosinophilic Esophagitis and Prurigo Nodularis
Epsolay - A Benzoyl Peroxide Cream for Rosacea
Transdermal Dextroamphetamine (Xelstrym) for ADHD
COVID-19 Update: Evusheld Unlikely to Neutralize XBB.1.5 Omicron Variant
In Brief: A New Indication for Dabrafenib (Tafinlar) and Trametinib (Mekinist) Combination Therapy
Table: Inhibitors and Inducers of CYP Enzymes, P-Glycoprotein, and Other Transporters
Tremelimumab (Imjudo) for Metastatic NSCLC
Drugs for Hypothyroidism
Deucravacitinib (Sotyktu) for Plaque Psoriasis
In Brief: Expanded Access to Mifepristone
In Brief: Semaglutide (Wegovy) for Weight Loss in Children
In Brief: Zanubrutinib (Brukinsa) for CLL or SLL
Pirtobrutinib (Jaypirca): A Fourth Bruton's Tyrosine Kinase Inhibitor for Mantle Cell Lymphoma
In Brief: A Second Indication for Tucatinib (Tukysa)
Antiviral Drugs for COVID-19 in Vaccinated Outpatients
EUVIMED